Ulcerative colitis trials in Austria

In Austria 14 Also abroad 381

14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Innsbruck, Linz, Salzburg
Age
18 years and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Graz, Innsbruck, Vienna
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 2Taking people
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Where
Vienna
Age
18 years to 80 years
People
252 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07186101
Phase 3Taking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Graz, Klagenfurt Am Woerthersee, Linz, Salzburg, St. Poelten, Vienna, Wels
Age
18 years and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
No phaseTaking people
A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis
Where
Vienna
Age
18 years and over
People
35
Run by
Janssen-Cilag Pharma GmbH
See details and how to joinNCT07606339
Phase 2Taking people
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Where
Salzburg
Age
12 years to 17 years
People
36 worldwide
Run by
Pfizer
See details and how to joinNCT05287126 · EU 2022-500345-25-00
Phase 2Taking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Innsbruck, Linz, Salzburg, Vienna
Age
18 years to 75 years
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
Phase 3Taking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Vienna
Age
16 years to 80 years
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996
Phase 3Taking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Krems, Salzburg
Age
16 years to 80 years
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
Phase 2Taking people
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Where
Vienna
Age
18 years and over
People
75 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-522338-30-00 · EU 2025-522338-30-00
Phase 3Taking people
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Where
Vienna
Age
2 years to 19 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT04844606
Phase 2Taking people
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Graz
Age
18 years and over
People
70 worldwide
Run by
Odyssey Therapeutics Inc.
See details and how to join2024-520201-39-00 · EU 2024-520201-39-00
Phase 2Taking people
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Graz
Age
18 years to 75 years
People
57 worldwide
Run by
Odyssey Therapeutics, Inc.
See details and how to joinNCT06850727
No phaseTaking people
Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
Where
Feldkirch, Graz, Innsbruck, Klagenfurt, Linz, Salzburg, Vienna, Villach
Age
0 years to 18 years
People
120
Run by
Medical University Innsbruck
See details and how to joinNCT06954311